| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 66.855 | 97.577 | 116.164 | 118.814 | 138.831 | 74.463 | 80.108 | 199.621 | 206.821 | 175.500 |
| Total Income - EUR | 71.537 | 103.755 | 126.978 | 129.575 | 148.450 | 83.819 | 132.841 | 200.329 | 206.821 | 176.368 |
| Total Expenses - EUR | 59.522 | 86.956 | 96.094 | 105.197 | 94.374 | 66.968 | 71.183 | 141.894 | 134.430 | 120.004 |
| Gross Profit/Loss - EUR | 12.015 | 16.799 | 30.885 | 24.378 | 54.076 | 16.852 | 61.658 | 58.435 | 72.391 | 56.364 |
| Net Profit/Loss - EUR | 9.920 | 15.823 | 29.723 | 23.190 | 52.688 | 16.119 | 60.716 | 56.485 | 70.365 | 51.204 |
| Employees | 3 | 4 | 5 | 5 | 5 | 2 | 2 | 3 | 5 | 2 |
Check the financial reports for the company - Nicomedica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 102.097 | 148.813 | 237.093 | 233.810 | 197.078 | 191.185 | 161.100 | 169.091 | 128.513 | 90.092 |
| Current Assets | 30.687 | 29.006 | 14.733 | 25.510 | 6.958 | 24.313 | 71.980 | 17.038 | 40.958 | 80.139 |
| Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Receivables | 109 | 18.365 | 52 | 116 | 0 | 0 | 0 | 852 | 834 | 336 |
| Cash | 30.578 | 10.641 | 14.682 | 25.394 | 6.958 | 24.313 | 71.980 | 16.186 | 40.125 | 39.618 |
| Shareholders Funds | 95.829 | 63.797 | 92.441 | 113.934 | 164.416 | 177.417 | 229.819 | 176.301 | 161.307 | 141.248 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 17.072 | 114.021 | 126.328 | 122.523 | 26.603 | 34.534 | 3.261 | 9.828 | 8.164 | 28.983 |
| Income in Advance | 19.883 | 43.563 | 33.058 | 22.863 | 13.017 | 3.546 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Nicomedica Srl